Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression

• Main Authors: Raymond Yan (Author), Tyler Marshall (Author), Atul Khullar (Author), Travis Nagle (Author), Jake Knowles (Author), Mai Malkin (Author), Brittany Chubbs (Author), Jennifer Swainson (Author)
• Format: Book
• Published: SAGE Publishing, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Intravenous (IV) ketamine is a rapid acting antidepressant used primarily for treatment-resistant depression (TRD). It has been suggested that IV ketamine's rapid antidepressant effects may be partially mediated via improved sleep and changes to the circadian rhythm. Objectives: Thi...